Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Angiodynamics (ANGO) Income from Continuing Operations (2016 - 2026)

Angiodynamics' Income from Continuing Operations history spans 17 years, with the latest figure at 8084000.0 for Q1 2026.

  • For Q1 2026, Income from Continuing Operations fell 83.44% year-over-year to 8084000.0; the TTM value through Feb 2026 reached 31387000.0, up 24.17%, while the annual FY2025 figure was 33993000.0, 81.56% up from the prior year.
  • Income from Continuing Operations reached 8084000.0 in Q1 2026 per ANGO's latest filing, down from 6350000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 45884000.0 in Q3 2023 to a low of 187736000.0 in Q1 2024.
  • Average Income from Continuing Operations over 5 years is 18079117.65, with a median of 9485000.0 recorded in 2023.
  • Peak YoY movement for Income from Continuing Operations: surged 452.85% in 2023, then crashed 1879.29% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 8486000.0 in 2022, then tumbled by 242.3% to 29048000.0 in 2023, then soared by 63.03% to 10738000.0 in 2024, then surged by 40.86% to 6350000.0 in 2025, then decreased by 27.31% to 8084000.0 in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Income from Continuing Operations are 8084000.0 (Q1 2026), 6350000.0 (Q4 2025), and 10903000.0 (Q3 2025).